HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Letter to the Editor Regarding "Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma".

AuthorsJie Zhang, Junlong Li, Qiufei Ma, Hongbo Yang, James Signorovitch, Eric Wu
JournalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation (Biol Blood Marrow Transplant) Vol. 26 Issue 12 Pg. e333-e334 (12 2020) ISSN: 1523-6536 [Electronic] United States
PMID32950695 (Publication Type: Letter, Research Support, Non-U.S. Gov't, Comment)
Chemical References
  • Antigens, CD19
  • Biological Products
  • Receptors, Antigen, T-Cell
  • tisagenlecleucel
  • axicabtagene ciloleucel
Topics
  • Antigens, CD19 (therapeutic use)
  • Biological Products
  • Humans
  • Immunotherapy, Adoptive
  • Lymphoma, B-Cell
  • Receptors, Antigen, T-Cell

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: